StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth gross margin

Gross margin is gross profit as a percentage of revenue.

Vireo Growth's gross margin for the twelve months ending Sep 30, 2026 was 47.4%. For fiscal 2025 it was 47.3%, against 51.1% the year before. The highest annual figure on record is 51.1% in fiscal 2024.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202547.3%−3.8
FY2024Dec 31, 202451.1%+1.0
FY2023Dec 31, 202350.0%+8.6
FY2022Dec 31, 202241.4%+5.1
FY2021Dec 31, 202136.4%+1.6
FY2020Dec 31, 202034.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202642.5%+1.7
Q2 FY2026Jun 30, 202645.5%+3.1
Q1 FY2026Mar 31, 202655.8%+5.2
Q4 FY2025Dec 31, 202554.5%+3.9
Q3 FY2025Sep 30, 202540.8%−8.2
Q2 FY2025Jun 30, 202542.4%−11.6
Q1 FY2025Mar 31, 202550.6%−0.2
Q4 FY2024Dec 31, 202450.6%+0.7
Q3 FY2024Sep 30, 202449.0%−4.5
Q2 FY2024Jun 30, 202454.0%+7.8
Q1 FY2024Mar 31, 202450.8%+1.0
Q4 FY2023Dec 31, 202349.9%+5.2
Q3 FY2023Sep 30, 202353.5%+2.9
Q2 FY2023Jun 30, 202346.2%−3.0
Q1 FY2023Mar 31, 202349.9%+34.0
Q4 FY2022Dec 31, 202244.7%+28.9
Q3 FY2022Sep 30, 202250.6%+12.3
Q2 FY2022Jun 30, 202249.2%+0.6
Q1 FY2022Mar 31, 202215.9%−26.7
Q4 FY2021Dec 31, 202115.8%−26.9
Q3 FY2021Sep 30, 202138.3%−1.5
Q2 FY2021Jun 30, 202148.6%+19.2
Q1 FY2021Mar 31, 202142.6%+15.5
Q4 FY2020Dec 31, 202042.7%–
Q3 FY2020Sep 30, 202039.8%–
Q2 FY2020Jun 30, 202029.4%–
Q1 FY2020Mar 31, 202027.0%–

More Vireo Growth figures

See a number that looks wrong?